NUVL.NASDAQNuvalent, INC

SCHEDULE: FMR LLC Discloses 12.6% Stake in Nuvalent Inc.

Sentiment:

Schedule 13G Filing


FMR LLC, through its subsidiaries, has reported beneficial ownership of 12.6% of Nuvalent Inc.'s Class A Common Stock as of March 31, 2026.

Summary

  • FMR LLC and its affiliates, including Abigail P. Johnson, have filed a Schedule 13G indicating beneficial ownership of 9,252,159.10 shares of Nuvalent Inc. Class A Common Stock.
  • This holding represents 12.6% of the total outstanding Class A Common Stock as of March 31, 2026.
  • The filing is an amendment (Amendment No. 4) to a previous filing.
  • FMR LLC is identified as a holding company (HC) and Abigail P. Johnson is identified as an investment company (IN).
  • Several subsidiaries of FMR LLC, including FIAM LLC, Fidelity Institutional Asset Management Trust Company, Fidelity Management & Research Company LLC, and Strategic Advisers LLC, are involved in the beneficial ownership.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it indicates significant investment from a major financial institution, but provides no operational or financial updates on Nuvalent Inc. itself.

Positives

  • FMR LLC, a significant investment management firm, has taken a substantial stake in Nuvalent Inc., suggesting confidence in the company's prospects.
  • The filing indicates that FMR LLC and its subsidiaries manage a large portfolio, with 9,252,159.10 shares held.

Risks

  • The filing does not explicitly detail any risks associated with Nuvalent Inc. itself, as it is a Schedule 13G filing focused on ownership.
  • Potential risks for FMR LLC could include market volatility affecting the value of their Nuvalent Inc. investment.

Future Outlook

This filing does not contain forward-looking statements or guidance from Nuvalent Inc. It solely reports on the ownership stake of FMR LLC.

Industry Context

StockSavvy.ai notes that significant institutional ownership, as reported by FMR LLC, often signals investor confidence and can influence market perception and stock liquidity for companies in the biotechnology or pharmaceutical sector, where Nuvalent Inc. operates.

Stakeholder Impact

  • Shareholders: The increased institutional ownership may be viewed positively, potentially increasing investor confidence and liquidity.
  • Nuvalent Inc. Management: The significant stake held by FMR LLC may lead to increased engagement or influence from the investor.
  • Competitors: The substantial investment by a major player like FMR LLC could signal a positive outlook for the sector Nuvalent Inc. operates in.

Next Steps

  • FMR LLC will continue to hold and potentially adjust its stake in Nuvalent Inc.
  • Nuvalent Inc. will continue its operations and report its financial and operational results in subsequent filings.

Key Dates

DateDescription
03/31/2026Date of Event Which Requires Filing of this Statement (Reporting period end date)
04/13/2026Effective date of Power of Attorney for FMR LLC and Abigail P. Johnson.
04/29/2026Date of previous Schedule 13G filing by FMR LLC.
05/05/2026Date of joint filing and certification.

Keywords

Nuvalent Inc., FMR LLC, Schedule 13G, Class A Common Stock, Beneficial Ownership, Investment Management, Abigail P. Johnson, Fidelity, SEC Filing, Equity Holding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.